Evidence map›Paper›PMID 32541879›Full record

ArticleNature cell biology2020

Neural metabolic imbalance induced by MOF dysfunction triggers pericyte activation and breakdown of vasculature.

Bilal N Sheikh, Sukanya Guhathakurta, Tsz Hong Tsang, Marius Schwabenland, Gina Renschler, Benjamin Herquel, Vivek Bhardwaj, Herbert Holz, Thomas Stehle, Olga Bondareva and 17 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. bioRxiv : the preprint server for biology · 2026
    Article
  5. Review
  6. Microtubule Minus-End Binding Proteins in Cancer: Advances.Diagnostics (Basel, Switzerland) · 2025
    Review
  7. Integrin α8-Mediated Pericyte Morphogenesis Controls Blood-Brain Barrier Integrity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  8. Article
  9. Article
  10. Review
  11. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 2 countries.

Bilal N SheikhMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-1970-6236
Sukanya GuhathakurtaMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-8287-9041
Tsz Hong TsangMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Marius SchwabenlandInstitute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0003-2205-5427
Gina RenschlerMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-6382-9815
Benjamin HerquelMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Vivek BhardwajMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-5570-9338
Herbert HolzMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Thomas StehleMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Olga BondarevaInstitute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Freiburg, Germany.
Nadim AizaraniMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Omar MossadFaculty of Biology, Albert Ludwig University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0003-4329-7804
Oliver KretzIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wilfried ReichardtMedical Physics, Department of Radiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-8888-399X
Aindrila ChatterjeeMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Laura J BraunMax Planck Institute for Molecular Biomedicine, Münster, Germany.
Julien ThevenonInserm UMR 1231 GAD, Genetics of Developmental disorders and Centre de Référence Maladies Rares Anomalies du Développement et syndromes malformatifs FHU TRANSLAD, Université de Bourgogne-Franche Comté, Dijon, France.
Herve SarteletUF de foetopathologie, Service de génétique et procréation, CHU Grenoble-Alpes, Grenoble, France.
Thomas BlankInstitute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.
Dominic GrünMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-3364-5898
Dominik von ElverfeldtMedical Physics, Department of Radiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Tobias B HuberIII. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dietmar VestweberMax Planck Institute for Molecular Biomedicine, Münster, Germany.
Sergiy AvilovMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Marco PrinzInstitute of Neuropathology, Medical Faculty, University of Freiburg, Freiburg, Germany.ORCID http://orcid.org/0000-0002-0349-1955
Joerg M BuescherMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-6547-0076
Asifa AkhtarMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. akhtar@ie-freiburg.mpg.de.ORCID http://orcid.org/0000-0001-8973-6193
University of Freiburg · DEMax Planck Institute of Immunobiology and Epigenetics · DEMax Planck Institute for Molecular Biomedicine · DEUniversität Hamburg · DECentre Hospitalier Universitaire de Grenoble · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in chromatin-modifying complexes and metabolic enzymes commonly underlie complex human developmental syndromes affecting multiple organs. A major challenge is to determine how disease-causing genetic lesions cause deregulation of homeostasis in unique cell types. Here we show that neural-specific depletion of three members of the non-specific lethal (NSL) chromatin complex-Mof, Kansl2 or Kansl3-unexpectedly leads to severe vascular defects and brain haemorrhaging. Deregulation of the epigenetic landscape induced by the loss of the NSL complex in neural cells causes widespread metabolic defects, including an accumulation of free long-chain fatty acids (LCFAs). Free LCFAs induce a Toll-like receptor 4 (TLR4)-NFκB-dependent pro-inflammatory signalling cascade in neighbouring vascular pericytes that is rescued by TLR4 inhibition. Pericytes display functional changes in response to LCFA-induced activation that result in vascular breakdown. Our work establishes that neurovascular function is determined by the neural metabolic environment.

Indexed as

AnimalsBrainCell NucleusChromatinFatty AcidsFemaleFetusHistone AcetyltransferasesHumansInflammationMaleMetabolomeMice, Inbred C57BLMice, KnockoutNeovascularization, PathologicNeuronsChromatinFatty AcidsHistone AcetyltransferasesKat8 protein, mouseNuclear Proteins

Identifiers

PMID32541879
OpenAlexW3035114957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.